SONOMA PHARMACEUTICALS INC (SNOA)
US83558L2043 - Common Stock
SONOMA PHARMACEUTICALS INC
NASDAQ:SNOA (5/1/2024, 4:28:22 PM)
After market: 0.1535 +0 (+0.2%)0.1532
-0.01 (-3.59%)
Company Profile
Sonoma Pharmaceuticals, Inc. engages in the development and production of hypochlorous acid (HOCl) products for wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company is headquartered in Boulder, Colorado and currently employs 8 full-time employees. The company went IPO on 2007-01-26. The firm's product offerings include Regenacyn Advanced Scar Gel, Regenacyn Plus Scar Gel, Rejuvacyn Advanced Skin Repair Cooling Mist, Pediacyn Skin Care, Microcyn, Ocucyn Eyelid and Eyelash Cleanser, Microdacyn60 Oral Care, Podiacyn Advanced Everyday Foot Care, and MicrocynAH. Regenacyn Advanced Scar Gel helps to improve the overall appearance of scars while reducing pain, itch, redness, and inflammation. Regenacyn Plus is a prescription-strength scar gel which is available as an office dispense product through dermatology practices and medical spas. Pediacyn is a pediatric dermatology and wound care product for over-the-counter use. MicrocynAH is a HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.
Company Info
SONOMA PHARMACEUTICALS INC
5445 Conestoga Court, Suite 150
Boulder COLORADO 30189
P: 18007599305
CEO: Amy Trombly
Employees: 8
Website: https://sonomapharma.com/
SNOA News
5 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time to dive into the biggest pre-market stock movers as we check out all of the hottest trading news for Tuesday morning!
6 months ago - Seeking AlphaSonoma Pharmaceuticals files a mixed shelf offering (NASDAQ:SNOA)Sonoma Pharmaceuticals files mixed shelf offering prospectus with an aggregate initial offering price of $51.3M; not an offer to sell securities.
SNOA Twits
Here you can normally see the latest stock twits on SNOA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
